MULTIPLE MYELOMA IN REMISSION

Clinical trials for MULTIPLE MYELOMA IN REMISSION explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYELOMA IN REMISSION trials appear

Sign up with your email to follow new studies for MULTIPLE MYELOMA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Off-the-shelf CAR-T therapy takes on multiple myeloma

Disease control Recruiting now

This early-phase study tests a universal (off-the-shelf) CAR-T cell therapy for people with multiple myeloma whose cancer is in remission but who have limited treatment options. About 20 participants will receive the therapy to see if it is safe and can control the disease. The s…

Matched conditions: MULTIPLE MYELOMA IN REMISSION

Phase: PHASE1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control

Last updated May 01, 2026 15:57 UTC

MULTIPLE MYELOMA IN REMISSION

Get alerted when new MULTIPLE MYELOMA IN REMISSION trials appear

Off-the-shelf CAR-T therapy takes on multiple myeloma